Related Experiment Video
Updated: Nov 18, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas
Janis A Müller1, Rüdiger Groß1, Carina Conzelmann1
1Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.
Abstract:
Infection-related diabetes can arise as a result of virus-associated β-cell destruction. Clinical data suggest that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causing the coronavirus disease 2019 (COVID-19), impairs glucose homoeostasis, but experimental evidence that SARS-CoV-2 can infect pancreatic tissue has been lacking. In the present study, we show that SARS-CoV-2 infects cells of the human exocrine and endocrine pancreas ex vivo and in vivo. We demonstrate that human β-cells express viral entry proteins, and SARS-CoV-2 infects and replicates in cultured human islets. Infection is associated with morphological, transcriptional and functional changes, including reduced numbers of insulin-secretory granules in β-cells and impaired glucose-stimulated insulin secretion. In COVID-19 full-body postmortem examinations, we detected SARS-CoV-2 nucleocapsid protein in pancreatic exocrine cells, and in cells that stain positive for the β-cell marker NKX6.1 and are in close proximity to the islets of Langerhans in all four patients investigated. Our data identify the human pancreas as a target of SARS-CoV-2 infection and suggest that β-cell infection could contribute to the metabolic dysregulation observed in patients with COVID-19.
Insights
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects human pancreatic cells, including insulin-producing beta cells. This infection impairs insulin secretion, potentially contributing to metabolic issues seen in coronavirus disease 2019 (COVID-19).
Area of Science:
- Endocrinology
- Virology
- Pathology
Background:
- Diabetes can result from virus-associated beta-cell destruction.
- Clinical data suggest SARS-CoV-2 impairs glucose homeostasis, but direct evidence of pancreatic infection was lacking.
Purpose of the Study:
- To investigate if SARS-CoV-2 infects human pancreatic cells and affects beta-cell function.
- To determine the presence of SARS-CoV-2 in pancreatic tissue from COVID-19 patients.
Main Methods:
- Ex vivo and in vivo studies using human pancreatic cells and islets.
- Analysis of viral entry proteins, viral replication, and beta-cell function (insulin secretion).
- Postmortem examination of pancreatic tissue from COVID-19 patients for SARS-CoV-2 presence.
Main Results:
- SARS-CoV-2 infects human exocrine and endocrine pancreatic cells, including beta-cells, which express viral entry proteins.
- Infection leads to morphological and transcriptional changes, reduced insulin granules, and impaired glucose-stimulated insulin secretion.
- SARS-CoV-2 nucleocapsid protein was detected in pancreatic cells of COVID-19 patients.
Conclusions:
- The human pancreas is a target for SARS-CoV-2 infection.
- SARS-CoV-2 infection of pancreatic beta-cells may contribute to metabolic dysregulation in COVID-19.
Related Concept Videos
Insulin Secretory Vesicles
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Cells and Secretions of the Pancreas
Exocrine function is carried out by acinar cells, organized into clusters known as acini. These cells contribute to digestion by releasing substantial quantities of enzyme-rich, alkaline digestive juices.
Concurrently, the dispersed clusters of endocrine cells throughout the...
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...

